The Good & The Bad, AI Holy Grail, Addressing America’s Cancer Drug Shortage 6/2/23

This morning’s jobs report had something for the hawks and the doves. We’ll debate the best move for the Fed and investors’ best move in the market. Plus, our guest says there’s a “holy grail” setup in the AI space. She’ll tell us what it is and how she’s playing it. And the CEO of Bristol-Myers Squibb joins Kelly as the ASCO conference kicks off. How are they helping solve America’s cancer drug shortage? He’ll explain.